Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
19.15 M
About Procaps Group, S.A.
Sector
CEO
Jose Antonio Toledo Vieira
Headquarters
Luxembourg
Website
Founded
1977
ISIN
LU2376511205
FIGI
BBG00ZVY4GS3
Procaps Group SA is an international healthcare and pharmaceutical company. The firm is engaged in the developing of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It operates through the following segments: NextGel, Procaps Colombia, CAN, CASAND, and Diabetrics. The NextGel segment is involved in the manufacturing and distribution of prescription and over-the-counter pharmaceutical products in USA, Brazil, and Colombia. The Procaps Colombia segment is focused on the manufacturing and distribution of prescription and over-the-counter pharmaceutical products in Colombia. The CAN segment deals with the manufacturing and distribution of prescription and over-the-counter pharmaceutical products in Northern Central America: Salvador, Guatemala, Nicaragua, and Honduras. The CASAND segment offers pharmaceutical products in Southern Central America that include Panama and Costa Rica, and the North Andes District that include Ecuador, Peru, and Bolivia. The Diabetrics segment consists of the diabetes solutions and chronic disease management tool. The company was founded by Ruben Minski in 1977 and is headquartered in Luxembourg.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PROC is 1.36 USD — it has increased by 38.04% in the past 24 hours. Watch Procaps Group, S.A. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Procaps Group, S.A. stocks are traded under the ticker PROC.
PROC stock has risen by 84.06% compared to the previous week, the month change is a −31.35% fall, over the last year Procaps Group, S.A. has showed a −50.55% decrease.
PROC reached its all-time high on Oct 22, 2021 with the price of 11.98 USD, and its all-time low was 0.50 USD and was reached on Nov 19, 2024. View more price dynamics on PROC chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PROC stock is 19.67% volatile and has beta coefficient of 0.69. Track Procaps Group, S.A. stock price on the chart and check out the list of the most volatile stocks — is Procaps Group, S.A. there?
Today Procaps Group, S.A. has the market capitalization of 143.29 M, it has increased by 60.87% over the last week.
Yes, you can track Procaps Group, S.A. financials in yearly and quarterly reports right on TradingView.
Procaps Group, S.A. is going to release the next earnings report on Nov 27, 2024. Keep track of upcoming events with our Earnings Calendar.
No, PROC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PROC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Procaps Group, S.A. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Procaps Group, S.A. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Procaps Group, S.A. stock shows the sell signal. See more of Procaps Group, S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.